Anand Grover | Apr 2, 2013, 03.11 AM IST After 2005 India started granting product patents on medicines. However, Section 3(d), one of the safeguards introduced by Parliament, seeks to prevent patenting of new forms of known substances unless they exhibit enhanced efficacy. Were it not for section 3(d), the...Read More
Check against delivery Statement by Mr. Anand Grover Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health 22nd session of the Human Rights Council Human rights Council Annual Full-day meeting on the Rights of the Child 7 March 2013...Read More
A Comparison of the IPC, Criminal Law (Amendment) Bill 2012, Justice Verma Committee and Criminal Law (...
The Chart mapping legal changes regarding sexual offences. DownloadRead More
Download the SpeechRead More
Poster from the 6th National Conference.Read More
22 February 2013, New Delhi, Tripti Tandon Non-consensual acts in a commercial context amount to rape: no second opinion about it! ‘When I say I didn’t consent to sex, they say you can’t be raped. But when I say I consented, they say you are being raped.’ This is the...Read More
Hope for hep-c patients: Patients succeed in overturning first ever product patent on medicine in ...
2 November 2012, New Delhi. In a landmark victory for patients’ groups fighting against patents to ensure access to medicines, the Intellectual Property Appellate Board (IPAB) has revoked a patent granted in India to F. Hoffmann-La Roche AG (Roche) for pegylated interferon alfa-2a (Pegasys, a medicine used to treat Hepatitis...Read More
Anand Grover Marred by disruptions and adjournments by the Opposition, the monsoon session of Parliament was a complete washout with minimal business being conducted. While the government took decades to table the much-hyped Lokpal Bill in Parliament, one wonders when important legislation like the HIV/Aids Bill, which aims to protect...Read More